OCS.
company based in Latvia
- Reports this week
- 4
- Active events
- 3
- Connections
- 65
What's happening
Active this week
-
Cannabis products were listed with OCS and delivered to BC Cannabis Stores, with product reloading occurring in Saskatchewan.Some support1 report
-
OCS held a presentation at a meeting in Toronto, while Céline Louapre was identified as the principal investigator of the ACUITY trial.Some support1 report
-
OCS, a global biopharmaceutical company, is mentioned in the context of Oculis's research involving Anat Galor.Some support1 report
Earlier this month
-
Minneapolis City Council proposed eliminating OCS, prompting Jacob Frey to warn that the move would jeopardize city services.Some support1 report
-
OCS team is located within the Greater Chennai Corporation's Adyar zone.Some support1 report
-
OCS is filing reports with the SEC and trading on the NASDAQ stock exchange.Some support2 reports
-
OCS, led by CEO Sherif, sponsored an event in New Orleans on October 7, 2026.Some support1 report
-
OCS is anticipated to become a new revenue stream for the company, building on its partnership with Nvidia.Some support3 reports
-
Summit 2026 is taking place in Las Vegas, Nevada, with OCS sponsoring clinical trials.Some support3 reports
One to three months ago
-
OCS is listed on the Nasdaq stock exchange and its financial reporting is tied to the US market.Some support2 reports1 development inside
-
CS overreach is impacting the operational independence of OCS in Kenya.Some support1 report
-
OCS is now a revenue segment of ADI.Some support1 report
-
OCS and North Sails participated in the XOD regatta on August 2, 2026.Some support2 reports
-
OCS is acquiring Mitie Group plc through a Scheme of Arrangement.Well supported8 reports1 development inside
-
OCS recommended a cash acquisition of Mitie shares, with Chetan Patel holding shares requiring irrevocable undertakings.Some support1 report
Gone quiet
No new reports in 90+ days-
A £5.1bn bid for easyJet was announced, while OCS acquired Mitie Group plc shares at a premium.Some support1 report
-
OCS is seeking Priority Medicines and Breakthrough Therapy designations for Privosegtor for optic neuritis from the FDA and EMA.Some support2 reports
-
An investigation into OCS is underway, focusing on market integrity issues in New York City.Some support2 reports
-
The FDA granted conditional IDE approval for TransMedics utilizing the OCS Heart System.Some support3 reports
-
Oculis Holding AG secured an upsized loan facility from BlackRock and issued results from Zug, Switzerland.Some support2 reports1 development inside
-
Nathan Miller assists in Oculis securities investigation.Some support1 report
-
OCS appointed Sebastian Wolf as Chief Medical Advisor for Ophthalmology in Zug on August 25, 2025.Some support1 report
-
OCS technology is cited as a key factor driving the growth of Transmedics.Some support4 reports1 development inside
-
OCS technology was cited for keeping donated organs healthy and providing better outcomes for transplant recipients.Some support5 reports
-
BlackRock began managing funds for Oculis' loan facility.Some support1 report
-
OCS appointed Snehal Shah as President of R&D on August 12, 2025.Some support1 report
-
OCS collaborated with EURETINA on an award, recognizing Prithvi Ramtohul with the Tadayoni Award, which was presented by Anat Loewenstein.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around OCS this week
News at the entities that move OCS most-
FDA StructuralFDA confirmed CMC and device plans are Phase 3 ready, coinciding with strengthening of US and EU patent estates.Moves OCS
-
ADI StructuralChunghwa Telecom participated in a hackathon sponsored by ADI and guided by the Ministry of Digital Affairs, with technical support from AWS.Moves OCS
-
European Medicines Agency StructuralGlenn attended a congress in Amsterdam and participated in a panel with an official from the European Medicines Agency.Moves OCS
-
Nasdaq StructuralThreads gains users from Instagram base while SpaceX reports its listing on Nasdaq.Moves OCS
-
Kenya StructuralMnangagwa replaces Ruto as chairperson of COMESA, highlighting tripartite regional relationships between blocs.Moves OCS
-
London Stock Exchange StructuralThe Global Smaller Companies Trust plc purchased shares on the London Stock Exchange, with disclosure made per FCA UK Listing Rule.Moves OCS
Connections
The 38 strongest of 65, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Transmedics Structural
OCS technology is the core product driving Transmedics' growth and market operations in organ transplant procedures.
-
ADI Structural
OCS functions as a defined revenue segment within the corporate structure of ADI.
-
European Medicines Agency Structural
OCS is undergoing the formal regulatory review process with the European Medicines Agency, culminating in the PRIME designation for its product.
-
FDA Structural
OCS relies on the FDA for product approval, clearance, and regulatory designations like Breakthrough Therapy.
-
Nasdaq Structural
OCS is formally listed and trades shares on the Nasdaq stock exchange.
-
Sherif Structural
Sherif holds the role of CEO at OCS.
-
Kenya Structural
Kenya's regulatory actions (CS overreach) impact the operational independence of OCS.
-
Céline Louapre Structural
Céline Louapre functions as the principal investigator for a trial associated with OCS.
Show all 38 connections
-
London Stock Exchange Structural
OCS relies on the London Stock Exchange as the operational venue for executing its corporate acquisitions.
-
SUMMIT Transactional
OCS is providing financial sponsorship for clinical trials being held at the Summit 2026 infrastructure event.
-
Anat Galor Operational
OCS features Anat Galor as a key opinion leader in its corporate communications.
-
Nvidia Operational
OCS is anticipated to derive new revenue streams from its operational relationship with Nvidia's market.
-
Minneapolis City Council Structural
The Minneapolis City Council is proposing the elimination of OCS.
-
Lumentum Holdings Transactional
Lumentum benefits commercially from OCS's pricing structure.
-
MarketBeat Mentioned together
MarketBeat provides average rating data and tracking information for OCS.
-
Galatea Mentioned together
The evidence suggests OCS is mentioned in the context of market leadership that impacts competitors.
-
BlackRock Transactional
BlackRock provides loan facility management and financing to OCS.
-
Nathan Miller Transactional
Nathan Miller is engaged to provide expert assistance regarding OCS's securities investigation.
-
Jacob Frey Structural
Jacob Frey warned that the elimination of OCS would jeopardize essential services.
-
Nairobi Operational
OCS actively collaborates with county teams in Nairobi.
-
New York City Shared context
OCS operates within the market and regulatory context of New York City, which is currently under investigation regarding market integrity issues.
-
Securities and Exchange Commission Structural
OCS is subject to formal regulatory oversight by the SEC, requiring the filing of official reports.
-
company Shared context
OCS is observed operating within the context of a general company structure.
-
Canton of Zug Shared context
OCS conducts corporate events and issues results while located in the Canton of Zug.
-
Greater Chennai Corporation Shared context
OCS operates within the administrative zone managed by the Greater Chennai Corporation.
-
Y. Chen Mentioned together
The evidence is insufficient to establish a relationship between OCS and Y. Chen.
-
Lorain County Shared context
OCS operates within the jurisdiction of Lorain County, providing support services to its residents.
-
Adyar Shared context
OCS maintains a physical presence within the Adyar zone.
-
Switzerland Shared context
OCS is headquartered and operates in Switzerland.
-
Iceland Shared context
OCS maintains operational presence and holds investor meetings within Iceland.
-
Toronto Shared context
OCS held a presentation meeting while operating in Toronto.
-
New Orleans Shared context
OCS is observed sponsoring an event within the geographical context of New Orleans.
-
Nevada Shared context
The single piece of evidence places an event in Nevada, but provides no direct coupling or interaction between Nevada and OCS.
-
MIaMI Shared context
OCS management is scheduled to attend a conference in Miami.
-
Microsoft Mentioned together
No evidence was found linking OCS and Microsoft in the provided timeline.
-
North Sails Shared context
Both companies shared a context by participating in the XOD regatta.
-
William Ruto Mentioned together
The provided evidence does not describe a relationship between OCS and William Ruto.
-
Google Mentioned together
No direct relationship between OCS and Google is observed in the provided evidence.
History
Events by the month they beganOctober 2026
6 events- Cannabis products were listed with OCS and delivered to BC Cannabis Stores, with product reloading occurring in Saskatchewan.
- OCS held a presentation at a meeting in Toronto, while Céline Louapre was identified as the principal investigator of the ACUITY trial.
- OCS, a global biopharmaceutical company, is mentioned in the context of Oculis's research involving Anat Galor.
- Minneapolis City Council proposed eliminating OCS, prompting Jacob Frey to warn that the move would jeopardize city services.
- OCS team is located within the Greater Chennai Corporation's Adyar zone.
- OCS, led by CEO Sherif, sponsored an event in New Orleans on October 7, 2026.
September 2026
1 eventAugust 2026
5 events- OCS is anticipated to become a new revenue stream for the company, building on its partnership with Nvidia.
- OCS is listed on the Nasdaq stock exchange and its financial reporting is tied to the US market.
- CS overreach is impacting the operational independence of OCS in Kenya.
- OCS is now a revenue segment of ADI.
- OCS and North Sails participated in the XOD regatta on August 2, 2026.
Show 2 earlier months
July 2026
4 events- OCS is acquiring Mitie Group plc through a Scheme of Arrangement.
- OCS recommended a cash acquisition of Mitie shares, with Chetan Patel holding shares requiring irrevocable undertakings.
- A £5.1bn bid for easyJet was announced, while OCS acquired Mitie Group plc shares at a premium.
- OCS is seeking Priority Medicines and Breakthrough Therapy designations for Privosegtor for optic neuritis from the FDA and EMA.
June 2026
11 events- Summit 2026 is taking place in Las Vegas, Nevada, with OCS sponsoring clinical trials.
- An investigation into OCS is underway, focusing on market integrity issues in New York City.
- The FDA granted conditional IDE approval for TransMedics utilizing the OCS Heart System.
- Oculis Holding AG secured an upsized loan facility from BlackRock and issued results from Zug, Switzerland.
- Nathan Miller assists in Oculis securities investigation.
- OCS appointed Sebastian Wolf as Chief Medical Advisor for Ophthalmology in Zug on August 25, 2025.
- OCS technology is cited as a key factor driving the growth of Transmedics.
- OCS technology was cited for keeping donated organs healthy and providing better outcomes for transplant recipients.
- BlackRock began managing funds for Oculis' loan facility.
- OCS appointed Snehal Shah as President of R&D on August 12, 2025.
- OCS collaborated with EURETINA on an award, recognizing Prithvi Ramtohul with the Tadayoni Award, which was presented by Anat Loewenstein.